Search Results
LIG1 deletion predicts chemotherapy resistance in triple-negative breast cancer
The importance of a biomarker-directed approach in triple-negative breast cancer
Possible new therapy found for chemo-resistant breast cancer
The challenges of treating early-stage TNBC
Triple-negative breast cancer: a potential new treatment is now in sight
What to do in patients with early-stage TNBC who have not achieved a pCR?
TRIPLE NEGATIVE SURVIVORS! (LISTEN UP)
Optimal chemotherapy combinations in TNBC gBRCA subtypes
Precision medicine for metastatic triple-negative breast cancer
TNBC: Updated Efficacy Results From IMpassion130
Revolutionising triple negative breast cancer treatment
TNBC: Using Checkpoint Inhibitors Alone or With Chemotherapy